Analysed BIOVIE INC -30 (BIVIW:NASDAQ) News Sources
Alliance Entertainment and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
18-09-2026
yahoo.com
New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global
19-09-2026
yahoo.com
New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global
26-09-2026
yahoo.com
BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting
14-10-2026
yahoo.com
BioVie to present Long COVID and Parkinson’s trial results at American Neurological Association meeting
14-10-2026
proactiveinvestors.com
Join Biovie's Exclusive Live Investor Webinar: Inside the SUNRISE-PD Topline Results
07-08-2026
yahoo.com
First Phosphate and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
14-08-2026
yahoo.com
BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
31-08-2026
yahoo.com
What is the current price of BIOVIE INC -30 (BIVIW:NASDAQ)?
The current price of BIOVIE INC -30 (BIVIW:NASDAQ) is $0.2301.
BIOVIE INC -30 (BIVIW:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOVIE INC -30 (BIVIW:NASDAQ) since the previous trading day is $-0.0299.
BIOVIE INC -30 (BIVIW:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOVIE INC -30 (BIVIW:NASDAQ) since the previous trading day is -11.5%.
What is the most recent average sentiment score for BIOVIE INC -30 (BIVIW:NASDAQ)?
The most recent average sentiment score for BIOVIE INC -30 (BIVIW:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for BIOVIE INC -30 (BIVIW:NASDAQ)?
The most recent sentiment for BIOVIE INC -30 (BIVIW:NASDAQ) is .
SEC-8K** Filing Available For BIOVIE INC -30 (BIVIW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.